Company Filing History:
Years Active: 2013-2014
Title: Andrew Pike: Innovator in Cancer Treatment
Introduction
Andrew Pike is a notable inventor based in Bishops Stortford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer. With a total of two patents to his name, his work is recognized for its potential impact on medical treatments.
Latest Patents
Andrew Pike's latest patents include innovative compounds that serve as inhibitors for various receptors involved in cancer progression. One of his patents focuses on bicyclic heterocyclic compounds as FGFR inhibitors. This invention relates to new bicyclic heterocyclic derivative compounds, pharmaceutical compositions comprising these compounds, and their use in treating diseases such as cancer. Another patent involves imidazo[1,2-a]pyridine compounds for use in treating cancer. This invention also pertains to new bicyclic heterocyclic derivative compounds of Formula (I), which are designed to inhibit FGFR, VEGFR, or PDGFR, showcasing their potential in cancer therapy.
Career Highlights
Andrew Pike is currently associated with Astex Therapeutics Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to finding effective treatments for serious diseases, particularly cancer.
Collaborations
Some of Andrew's notable coworkers include Valerio Berdini and Gilbert Besong. Their collaborative efforts contribute to the innovative environment at Astex Therapeutics Limited.
Conclusion
Andrew Pike's contributions to cancer treatment through his patented inventions highlight his role as a significant innovator in the pharmaceutical industry. His work continues to pave the way for advancements in medical therapies.